Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study

<div>Correlation between periprocedural glycemic variability (expressed as MAGE, MAGE-up, and CONGA-4) and postprocedural serum creatinine variation. CONGA-4: continuous overall net glycemic action at 4 hours; MAGE: mean amplitude glycemic excursions; MAGE-up: mean amplitude glycemic nadir-to-peak excursions.</div>

Journal of Diabetes Research

fig2

Figure 2

Figure 2: Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study 

Figure 2 | Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study 